Charles Schwab Investment Management Inc Amgen Inc Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 10,832,342 shares of AMGN stock, worth $3.46 Billion. This represents 0.72% of its overall portfolio holdings.

Number of Shares

10,832,342

Previous 10,393,110 4.23%

Holding current value

$3.46 Billion

Previous $2.99 Billion 2.89%

% of portfolio

0.72%

Previous 0.77%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $118 Million - $143 Million	439,232 Added 4.23%	10,832,342 $3.08 Billion
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $128 Million - $144 Million	-500,785 Reduced 4.6%	10,393,110 $2.99 Billion
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $76.1 Million - $94.5 Million	-347,963 Reduced 3.1%	10,893,895 $2.93 Billion
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $103 Million - $122 Million	480,421 Added 4.46%	11,241,858 $2.5 Billion
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $333 Million - $406 Million	1,474,151 Added 15.87%	10,761,437 $2.6 Billion

Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $11.6 Million - $14.8 Million	50,756 Added 0.55%	9,287,286 $2.44 Billion
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $64.6 Million - $72.9 Million	287,899 Added 3.22%	9,236,530 $2.08 Billion
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $29.7 Million - $33.1 Million	128,941 Added 1.46%	8,948,631 $2.18 Billion
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $20.7 Million - $22.9 Million	94,565 Added 1.08%	8,819,690 $2.13 Billion
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $112 Million - $128 Million	561,955 Added 6.88%	8,725,125 $1.96 Billion
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $196 Million - $229 Million	921,133 Added 12.72%	8,163,170 $1.74 Billion
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $204 Million - $226 Million	871,428 Added 13.68%	7,242,037 $1.77 Billion
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $797 Million - $929 Million	3,591,016 Added 129.19%	6,370,609 $1.59 Billion
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $5.02 Million - $5.98 Million	23,212 Added 0.84%	2,779,593 $639 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $10.4 Million - $11.6 Million	-44,454 Reduced 1.59%	2,756,381 $701 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $10.6 Million - $13 Million	-53,551 Reduced 1.88%	2,800,835 $661 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $9.02 Million - $12 Million	49,496 Added 1.76%	2,854,386 $579 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $12.4 Million - $15.9 Million	-65,428 Reduced 2.28%	2,804,890 $676 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $22.2 Million - $26.6 Million	-127,397 Reduced 4.25%	2,870,318 $555 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $7.75 Million - $9.08 Million	-46,466 Reduced 1.53%	2,997,715 $552 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $9.16 Million - $10.3 Million	-50,639 Reduced 1.64%	3,044,181 $578 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $6.33 Million - $7.39 Million	-35,501 Reduced 1.13%	3,094,820 $602 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $14.3 Million - $16.1 Million	-76,921 Reduced 2.4%	3,130,321 $649 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $12 Million - $13.5 Million	72,205 Added 2.3%	3,207,242 $592 Million
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $28.7 Million - $33.5 Million	-169,303 Reduced 5.12%	3,135,037 $534 Million
Q4 2017 Jan 17, 2018	BUY	$168.79 - $188.59 $20.8 Million - $23.2 Million	123,250 Added 3.87%	3,304,340 $575 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $532 Million - $608 Million	3,181,090	3,181,090 $593 Million

Others Institutions Holding AMGN

# of Institutions

2,929

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Amgen Inc Transaction History